Cargando…

TargetMine 2022: a new vision into drug target analysis

SUMMARY: We introduce the newest version of TargetMine, which includes the addition of new visualization options; integration of previously disaggregated functionality; and the migration of the front-end to the newly available Bluegenes service. AVAILABILITY AND IMPLEMENTATION: TargeteMine is access...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Yi-An, Allendes Osorio, Rodolfo S, Mizuguchi, Kenji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9477527/
https://www.ncbi.nlm.nih.gov/pubmed/35894632
http://dx.doi.org/10.1093/bioinformatics/btac507
_version_ 1784790380985712640
author Chen, Yi-An
Allendes Osorio, Rodolfo S
Mizuguchi, Kenji
author_facet Chen, Yi-An
Allendes Osorio, Rodolfo S
Mizuguchi, Kenji
author_sort Chen, Yi-An
collection PubMed
description SUMMARY: We introduce the newest version of TargetMine, which includes the addition of new visualization options; integration of previously disaggregated functionality; and the migration of the front-end to the newly available Bluegenes service. AVAILABILITY AND IMPLEMENTATION: TargeteMine is accessible online at https://targetmine.mizuguchilab.org/bluegenes. Users do not need to register to use the software. Source code for the different components listed in the article is available from TargetMine’s organizational account at http://github.com/targetmine. SUPPLEMENTARY INFORMATION: Supplementary data are available at Bioinformatics online.
format Online
Article
Text
id pubmed-9477527
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-94775272022-09-19 TargetMine 2022: a new vision into drug target analysis Chen, Yi-An Allendes Osorio, Rodolfo S Mizuguchi, Kenji Bioinformatics Applications Note SUMMARY: We introduce the newest version of TargetMine, which includes the addition of new visualization options; integration of previously disaggregated functionality; and the migration of the front-end to the newly available Bluegenes service. AVAILABILITY AND IMPLEMENTATION: TargeteMine is accessible online at https://targetmine.mizuguchilab.org/bluegenes. Users do not need to register to use the software. Source code for the different components listed in the article is available from TargetMine’s organizational account at http://github.com/targetmine. SUPPLEMENTARY INFORMATION: Supplementary data are available at Bioinformatics online. Oxford University Press 2022-07-27 /pmc/articles/PMC9477527/ /pubmed/35894632 http://dx.doi.org/10.1093/bioinformatics/btac507 Text en © The Author(s) 2022. Published by Oxford University Press. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Applications Note
Chen, Yi-An
Allendes Osorio, Rodolfo S
Mizuguchi, Kenji
TargetMine 2022: a new vision into drug target analysis
title TargetMine 2022: a new vision into drug target analysis
title_full TargetMine 2022: a new vision into drug target analysis
title_fullStr TargetMine 2022: a new vision into drug target analysis
title_full_unstemmed TargetMine 2022: a new vision into drug target analysis
title_short TargetMine 2022: a new vision into drug target analysis
title_sort targetmine 2022: a new vision into drug target analysis
topic Applications Note
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9477527/
https://www.ncbi.nlm.nih.gov/pubmed/35894632
http://dx.doi.org/10.1093/bioinformatics/btac507
work_keys_str_mv AT chenyian targetmine2022anewvisionintodrugtargetanalysis
AT allendesosoriorodolfos targetmine2022anewvisionintodrugtargetanalysis
AT mizuguchikenji targetmine2022anewvisionintodrugtargetanalysis